News Kayentis raises €7m for its digital trial engagement platfor... French tech company Kayentis has raised €7 million in private funding that will be invested in its digital platform for clinical trials.
Digital What future for pharma in a digital world? Heads of innovation, communication and digital strategy in pharma reflected at Frontiers Health 2018 on the implications of technological changes.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.